change from semaglutide to tirzepatide For the first time, and were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at maximum tolerated dose. The Switching From Semaglutide to Tirzepatide

Li H, Zhu Z, Liu J, Wang J, Qu C

Saxenda is a once-daily injectable medication FDA-approved for weight loss or management in adults with obesity or with overweight and weight-related medical condition

Other ingredients Filtered water, phosphoric acid, citric acid, malic acid, natural and artificial flavors, sucralose, potassium sorbate (preservative), sodium benzoate (preservative]

For CD45 immunostaining, the fixed sections were incubated with 1% bovine serum albumin (BSA)/PBS for 30 min at room temperature, followed by overnight incubation with the CD45-PE antibody (1:100

19 However, tumor cells also utilize GST to form a GSHX complex between antitumor drugs and GSH, proceeding to excrete the complex out of the cell by Pgp and MRP